Literature DB >> 11506194

Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase.

C Dong1, R J Davis, R A Flavell.   

Abstract

c-Jun N-terminal kinase (JNK) is one of the several main MAP kinase groups identified in mammals. Original studies by use of Jurkat T cells implicated JNK in T cell activation and interleukin (IL-2) expression. Recent advances using mouse genetic approaches have revealed novel functions of this pathway in primary mouse T cells. JNK is not essential for T-cell activation; instead, it is required for helper T differentiation into effector cells and their cytokine production. In this review, we summarize these advances in understanding the expression, function, and regulation of the JNK pathway in T-lymphocyte activation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506194     DOI: 10.1023/a:1010975124110

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

Review 1.  Lineage commitment in the immune system: the T helper lymphocyte grows up.

Authors:  L H Glimcher; K M Murphy
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

2.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.

Authors:  D D Yang; D Conze; A J Whitmarsh; T Barrett; R J Davis; M Rincón; R A Flavell
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

Review 3.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

Authors:  Y T Ip; R J Davis
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

Review 4.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  JNK is required for effector T-cell function but not for T-cell activation.

Authors:  C Dong; D D Yang; C Tournier; A J Whitmarsh; J Xu; R J Davis; R A Flavell
Journal:  Nature       Date:  2000-05-04       Impact factor: 49.962

6.  Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.

Authors:  D Yang; C Tournier; M Wysk; H T Lu; J Xu; R J Davis; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3.

Authors:  H Nishina; K D Fischer; L Radvanyi; A Shahinian; R Hakem; E A Rubie; A Bernstein; T W Mak; J R Woodgett; J M Penninger
Journal:  Nature       Date:  1997-01-23       Impact factor: 49.962

8.  JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development.

Authors:  K Sabapathy; Y Hu; T Kallunki; M Schreiber; J P David; W Jochum; E F Wagner; M Karin
Journal:  Curr Biol       Date:  1999-02-11       Impact factor: 10.834

9.  Defective T cell differentiation in the absence of Jnk1.

Authors:  C Dong; D D Yang; M Wysk; A J Whitmarsh; R J Davis; R A Flavell
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation.

Authors:  L Weiss; A J Whitmarsh; D D Yang; M Rincón; R J Davis; R A Flavell
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more
  19 in total

1.  Inhibition of RIP2/RIck/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK.

Authors:  Gretchen M Argast; Nelson Fausto; Jean S Campbell
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

Review 2.  Role of azithromycin in antiviral treatment: enhancement of interferon-dependent antiviral pathways and mitigation of inflammation may rely on inhibition of the MAPK cascade?

Authors:  Tapan Kumar Mohanta; Pietro Arina; Nanaocha Sharma; Paola Defilippi
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

3.  POSH Regulates CD4+ T Cell Differentiation and Survival.

Authors:  Cody A Cunningham; Leah N Cardwell; Yue Guan; Emma Teixeiro; Mark A Daniels
Journal:  J Immunol       Date:  2016-04-15       Impact factor: 5.422

4.  Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis.

Authors:  Bing-mu XIN; Xiao-xing WANG; Wen JIN; Hui-min YAN; Bing CUI; Xiao-wei ZHANG; Fang HUA; Hong-zhen YANG; Zhuo-wei HU
Journal:  Acta Pharmacol Sin       Date:  2010-11-29       Impact factor: 6.150

5.  Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury.

Authors:  Jayakumar Thangavel; Saheli Samanta; Sheeja Rajasingh; Bahar Barani; Yu-Ting Xuan; Buddhadeb Dawn; Johnson Rajasingh
Journal:  J Cell Sci       Date:  2015-06-26       Impact factor: 5.285

6.  Role of JNK during buccopharyngeal membrane perforation, the last step of embryonic mouth formation.

Authors:  Nathalie S Houssin; Navaneetha Krishnan Bharathan; Stephen D Turner; Amanda J G Dickinson
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

7.  The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  Jan Astermark; Sharyne M Donfield; Edward D Gomperts; John Schwarz; Erika D Menius; Anna Pavlova; Johannes Oldenburg; Bailey Kessing; Donna M DiMichele; Amy D Shapiro; Cheryl A Winkler; Erik Berntorp
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

8.  The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor.

Authors:  Mihail S Iordanov; Remy J Choi; Olga P Ryabinina; Thanh-Hoai Dinh; Robert K Bright; Bruce E Magun
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein kinase C-dependent pathways.

Authors:  Michael Stassen; Christian Müller; Christoph Richter; Christine Neudörfl; Lothar Hültner; Sucharit Bhakdi; Iwan Walev; Edgar Schmitt
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells.

Authors:  Daphne C Tsitoura; Paul B Rothman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.